CLINICAL INNOVATION ApS — Credit Rating and Financial Key Figures
CVR number: 29924880
Ydervang 5, 4300 Holbæk
info@clinicalinnovation.dk
tel: 33791390
www.clinicalinnovation.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 3 732.00 | 3 558.00 | 4 111.51 | 3 413.23 | 2 310.35 |
| Employee benefit expenses | -3 450.00 | -2 330.00 | -2 943.42 | -3 053.54 | -1 939.08 |
| Other operating expenses | -64.98 | ||||
| Total depreciation | - 153.00 | - 320.00 | - 291.65 | - 172.88 | - 148.63 |
| EBIT | 129.00 | 908.00 | 876.44 | 186.82 | 157.66 |
| Other financial income | 0.06 | 0.21 | |||
| Other financial expenses | - 103.00 | - 128.00 | - 118.18 | - 126.60 | - 151.66 |
| Pre-tax profit | 26.00 | 780.00 | 758.31 | 60.22 | 6.21 |
| Income taxes | -11.00 | - 191.00 | - 196.76 | -19.50 | -13.62 |
| Net earnings | 15.00 | 589.00 | 561.56 | 40.72 | -7.40 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 264.00 | 134.00 | |||
| Intangible rights | 53.00 | 24.00 | 58.84 | 32.02 | |
| Intangible assets total | 317.00 | 158.00 | 58.84 | 32.02 | |
| Land and waters | 621.00 | 601.00 | 581.02 | 560.98 | 542.61 |
| Buildings | 170.00 | ||||
| Machinery and equipment | 368.00 | 333.00 | 380.69 | 248.56 | |
| Tangible assets total | 791.00 | 969.00 | 914.02 | 941.67 | 791.17 |
| Investments total | 60.00 | 61.00 | 14.00 | 14.00 | |
| Non-current other receivables | 62.43 | ||||
| Long term receivables total | 62.43 | ||||
| Semifinished products | 322.64 | ||||
| Finished products/goods | 3 846.00 | 3 511.00 | 3 595.24 | 4 411.36 | 4 904.71 |
| Advance payments | 357.00 | 487.00 | 468.80 | ||
| Inventories total | 4 203.00 | 3 998.00 | 4 064.04 | 4 734.00 | 4 904.71 |
| Current trade debtors | 1 876.00 | 1 849.00 | 1 999.72 | 1 809.07 | 2 304.46 |
| Current amounts owed by group member comp. | 1.00 | 0.78 | 233.19 | 24.39 | |
| Prepayments and accrued income | 8.00 | 70.00 | 28.79 | 8.75 | |
| Current other receivables | 28.00 | 83.00 | 36.80 | 155.82 | 80.65 |
| Current deferred tax assets | 44.00 | 24.00 | 20.05 | 10.37 | 10.37 |
| Short term receivables total | 1 956.00 | 2 027.00 | 2 086.14 | 2 217.20 | 2 419.87 |
| Cash and bank deposits | 248.00 | 156.00 | 398.05 | 156.14 | 174.62 |
| Cash and cash equivalents | 248.00 | 156.00 | 398.05 | 156.14 | 174.62 |
| Balance sheet total (assets) | 7 575.00 | 7 369.00 | 7 524.68 | 8 121.86 | 8 336.39 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 126.00 | 126.00 | 126.00 | 126.00 | 126.00 |
| Shares repurchased | 70.00 | 500.00 | |||
| Retained earnings | 2 833.00 | 2 348.00 | 2 941.50 | 3 503.05 | 3 543.77 |
| Profit of the financial year | 15.00 | 589.00 | 561.56 | 40.72 | -7.40 |
| Shareholders equity total | 3 044.00 | 3 563.00 | 3 629.05 | 3 669.77 | 3 662.37 |
| Provisions | 0.34 | ||||
| Non-current loans from credit institutions | 275.00 | 125.00 | |||
| Non-current deferred tax liabilities | 172.00 | 192.32 | 13.18 | ||
| Non-current liabilities total | 275.00 | 297.00 | 192.32 | 13.18 | |
| Current loans from credit institutions | 1 430.00 | 605.00 | 963.67 | 1 823.51 | 1 568.31 |
| Current trade creditors | 1 140.00 | 1 431.00 | 936.97 | 1 412.67 | 1 764.96 |
| Current owed to group member | 432.00 | 174.00 | 623.47 | 579.82 | 970.76 |
| Short-term deferred tax liabilities | 130.00 | 3.00 | 3.37 | 192.32 | 26.45 |
| Other non-interest bearing current liabilities | 1 124.00 | 1 296.00 | 1 175.82 | 430.59 | 343.20 |
| Current liabilities total | 4 256.00 | 3 509.00 | 3 703.30 | 4 438.91 | 4 673.68 |
| Balance sheet total (liabilities) | 7 575.00 | 7 369.00 | 7 524.68 | 8 121.86 | 8 336.39 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.